Thomas Butt
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Pharmacy top 10%
Papers in
-
- Ophthalmology and Visual Impairment Studies 7
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Economic and Environmental Valuation 2
- Healthcare Policy and Management 2
- Co-authors
- Jos Kleijnen (1 shared paper)Nigel Armstrong (1 shared paper)Marie Westwood (1 shared paper)Regina Leadley (1 shared paper)Shelley de Kock (1 shared paper)Steve Ryder (1 shared paper)Ana Patrícia Marques (5 shared papers)Gary S. Rubin (6 shared papers)
- Journals
- Value in Health (6 papers)British Journal of Ophthalmology (3 papers)BMJ Open (3 papers)Orphanet Journal of Rare Diseases (3 papers)Applied Health Economics and Health Policy (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Thomas Butt
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 116
- Ophthalmology 144
- Pharmacy 26
- Epidemiology 167
- Genetics 51
- Aging 9
Countries citing papers authored by Thomas Butt
This map shows the geographic impact of Thomas Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Butt more than expected).
Fields of papers citing papers by Thomas Butt
This network shows the impact of papers produced by Thomas Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Butt. The network helps show where Thomas Butt may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Butt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 371 | |
| 2 | 2021 | 132 | |
| 3 | 2022 | 75 | |
| 4 | 2015 | 69 | |
| 5 | 2019 | 42 | |
| 6 | 2005 | 39 | |
| 7 | 2020 | 34 | |
| 8 | 2016 | 25 | |
| 9 | 2019 | 23 | |
| 10 | 2013 | 20 | |
| 11 | 2014 | 20 | |
| 12 | 2018 | 19 | |
| 13 | 2019 | 18 | |
| 14 | 2023 | 16 | |
| 15 | 2015 | 16 | |
| 16 | 2022 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2017 | 10 |
About Thomas Butt
Thomas Butt is a scholar working on Epidemiology, Economics and Econometrics, Physiology, General Health Professions and Ophthalmology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ophthalmology and Visual Impairment Studies (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Lysosomal Storage Disorders Research (5 papers), Retinal Diseases and Treatments (4 papers), Connective tissue disorders research (3 papers), Economic and Environmental Valuation (2 papers), Healthcare Policy and Management (2 papers) and Epilepsy research and treatment (2 papers). The work is most often cited by research in Ophthalmology (144 citations), Pharmacy (26 citations), Epidemiology (167 citations), Genetics (51 citations) and Aging (9 citations). Thomas Butt has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Jos Kleijnen, Nigel Armstrong, Marie Westwood, Regina Leadley, Shelley de Kock, Steve Ryder, Ana Patrícia Marques, Gary S. Rubin, Gordon G. Liu and Stephen Morris. Their work appears in journals such as Value in Health, British Journal of Ophthalmology, BMJ Open, Orphanet Journal of Rare Diseases and Applied Health Economics and Health Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.